Breast cancer immunohistochemical features in young women with BRCA1/2 mutations

Experimental Oncology

Volumn 31, Issue 3, 2009, Pages 174-178

  Zakhartseva, L M ^a   Gorovenko, N G ^b   Podolskaya, S V ^b   Anikusko, N F ^a   Lobanova, O E ^c   Pekur, K A ^a   Kropelnytskyi, V A ^a   Shurygina, O V ^a  

^a Kyiv City Oncologic Hospital   (Ukraine)

^b SHUPYK NATIONAL MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Ukraine)

^c BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

Author keywords

BRCA1 2 gene mutations; Breast cancer; Immunohistochemical markers; Young patients

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; TUMOR MARKER;

ADULT; ARTICLE; BREAST TUMOR; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MUTATION; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 77952371821     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Wildiers H, Kunkler I, Biganzoli L, et al. Management of breast cancer in elderly individuals: recommendations of the international Society of Geriatric Oncology. Lancet Oncology 2007; 8: 1101-15. (Pubitemid 350182967)
2. Hankey BF, Miller B, Curtis R, et al. Trends in breast cancer in younger women in contrast to older women. Natl Cancer Inst Monogr 1994; 16: 7-14.
3. Fedorenko ZP, Goulak L, Gorokh Ye, et al. Cancer in Ukraine 2006-2007. Bulletin of national cancer registry of Ukraine. Shchepotin IB, eds. Kyiv: 2008: C50.
4. Brinton LA, Sherman ME, Carreon JD, et al. Recent trends in breast cancer among younger women in the United States. JNCI 2008; 19: 1643-8.
5. Hartley MC, McKinley BP, Rogers EA, et al. Differential expression of prognostic factors and effect on survival in young (< or = 40) breast cancer patients; a case-control study. Am Surg 2006; 72: 1189-94. (Pubitemid 351837902)
6. Sidoni A, Cavaliere A, Bellezza A, et al. Breast cancer in young women: clinicopathological features and biological specificity. Breast 2003; 12: 247-50. (Pubitemid 36944150)
7. Aryandono T, Harijadi, Soeripto. Breast cancer in young women: prognostic and clinicopathological features. Asian Pac J Cancer Prev 2006; 7: 451-4.
8. Klauber-DeMore N. Tumor biology of breast cancer in young women. Breast Dis 2005- 2006; 23: 9-15.
9. Colleoni M, Rotmensz N, Robertson C, et al. Very young women (< 35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 2002; 13: 273-9. (Pubitemid 34704980)
10. Gluck I, Wolf I, Sadetzki S, et al. Prognostic characteristics in young premenopausal breast cancer patients compared to older premenopausal patients. In: Abstract book ASCO Annual Meeting Proceedings, 2003. Abstract 3604.
11. Lee W. Frequent loss of BRCA1 nuclear expression in young women with breast cancer: an immunohistochemical study from an area of low incidence but early onset. Appl Immunohistochem Mol Morphol 2002; 10: 310-5. (Pubitemid 35453688)
12. Musolino A, Bella M, Bortesi B, et al. BRCA mutation, molecular markers and clinical variables in early-onset breast cancer: a population-based study. Breast 2007; 16: 280-92. (Pubitemid 46796852)
13. Yin W, Lu J, Liu G, et al. The rule of mortality risk in young women (≤ 35 years) with primary breast cancer. J Clinical Oncol (ASCO Annual Meeting Proceedings) 2007; 25: Abstract 21098.
14. Frank TS, Deffenbaugh AM, Reid JE, et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 2002; 20: 1480-90. (Pubitemid 34260526)
15. Rennert G, Bisland-Naggen S, Barnett-Griness O, et al. Clinical outcomes of breast cancers of BRCA 1 and BRCA 2 mutations. N Engl J Med 2007; 357: 115-23. (Pubitemid 47057729)
16. Brose MS, Rebbeck TR, Calzone KA, et al. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002; 94:1365-72. (Pubitemid 35154141)
17. Thompson D, Easton DF. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358-65. (Pubitemid 35154140)
18. Nelson HD, Huffman LH, Fu R, et al. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence Review for the US Preventive Services Task Force. Ann Intern Med 2005; 143: 362-79.
19. Satagopan JM, Offit K, Foulkes W, et al. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev 2001; 10: 467-73. (Pubitemid 32701632)
20. Roa BB, Boyd AA, Volcik K, et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996; 14: 185-7. (Pubitemid 26338801)
21. Peelen T, van Vliet M, Petrij-Bosch A, et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 1997; 60: 1041-9. (Pubitemid 27194088)
22. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996; 13: 117-9. (Pubitemid 126528241)
23. Arason A, Jonasdottir A, Barkardottir RB, et al. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/2 linked breast cancer in Iceland. J Med Genet 1998; 35: 446-9. (Pubitemid 28252150)
24. Lepkova NV, Bogatyrev VN, Laktionov KP, et al. Genetic aspects of metachronic breast cancer. Russ Oncol J 2008; 2: 4-8 (In Russian).
25. Hagen AI, Tretli S, Maehle L, et al. Survival in Norwegian BRCA1 mutation carriers with breast cancer. Hered Cancer Clin Pract 2009; 7: 7.
26. Lakhani RS, Reis-Filho JS, Fulford L, et al. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 2005; 11: 5175-80. (Pubitemid 41003703)
27. Bernstein JL, Thompson WD, Casey G, et al. Comparison of techniques for the successful detection of BRCA1 mutations in fixed paraffin-embedded tissue. Cancer Epidemiol Biomarkers Prev 2002; 11: 809-14. (Pubitemid 35014882)
28. Chan PC, Wong BY, Ozcelik H, et al. Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR. Clin Chem 1999; 45: 1285-7. (Pubitemid 29424271)